Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Several approaches are now being developed and some TB vaccine candidates are in Phase I or II clinical trials. The concomitant design of ‘markers of vaccine take’ will aid to escort novel TB vaccines and to monitor patients with TB.
Citation: Magalhaes I, Ahmed RK, Vudattu N, Sizemore DR, Weichold F, et al. (2012) Mycobacterium tuberculosis Vaccination Imprints on T-Cell Dynamics Associated with Mycobacterium tuberculosis Challenge in Rhesus Monkeys. J Clin Cell Immunol S4:006doi: 10.4172/2155-9899.S4-006